Testing effectiveness (Phase 2)Ended earlyNCT00456846What this trial is testingFirst Line Therapy for Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Celgene 123
Not applicableUnknownNCT05153603What this trial is testingOutcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical SettingWho this might be right forOvarian Neoplasms Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Testing effectiveness (Phase 2)Study completedNCT01562990What this trial is testingPhase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second RelapseWho this might be right forDiffuse Large B-Cell Lymphoma The Lymphoma Academic Research Organisation 11
Large-scale testing (Phase 3)Active Not RecruitingNCT03793179What this trial is testingTesting the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerWho this might be right forLung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more National Cancer Institute (NCI) 600
Not applicableNot Yet RecruitingNCT07543510What this trial is testingLow-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaAtezolizumab Plus BevacizumabTransarterial Chemoembolization Third Affiliated Hospital, Sun Yat-Sen University 38
Not applicableStudy completedNCT04957160What this trial is testingCabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing CombinationWho this might be right forAdvanced Renal Cell Carcinoma (aRCC) Ipsen 281
Testing effectiveness (Phase 2)Study completedNCT00729482What this trial is testingRAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line TreatmentWho this might be right forStomach Neoplasm Asan Medical Center 54
Testing effectiveness (Phase 2)Ended earlyNCT01855724What this trial is testingClinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree CancerWho this might be right forCholangiocarcinomaGallbladder CarcinomaBiliary Carcinoma Hellenic Cooperative Oncology Group 29
Not applicableStudy completedNCT03519542What this trial is testingEpidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Spanish Oncology Genito-Urinary Group 62
Not applicableNot Yet RecruitingNCT07042282What this trial is testingComparison of Initial Treatment for Carpal Tunnel Syndrome Related to Rheumatic Diseases: Corticosteroid Injection Versus Nighttime SplintingWho this might be right forCarpal Tunnel Syndrome (CTS)Rheumatic Diseases Yun Qian 248
Testing effectiveness (Phase 2)Ended earlyNCT02173990What this trial is testingAflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).Who this might be right forMetastatic Colorectal Cancer Centre Oscar Lambret 40
Testing effectiveness (Phase 2)Study completedNCT05877820What this trial is testingEvaluate Efficacy and Safety of Lenvatinib Combined With Tislelizumab in Patients With FHRCCWho this might be right forFumarate Hydratase Deficient Renal Cell Carcinoma RenJi Hospital 20
Not applicableUnknownNCT04858828What this trial is testingInvestigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLCWho this might be right forBiomarkers Zhou Chengzhi 200
Testing effectiveness (Phase 2)Study completedNCT02392507What this trial is testingNab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLCWho this might be right forCarcinoma, Non-Small Cell Lung Cancer (NSCLC) Eli Lilly and Company 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT05767892What this trial is testingYK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsWho this might be right forAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Suzhou Puhe Pharmaceutical Technology Co., LTD 350
Large-scale testing (Phase 3)Ended earlyNCT00047632What this trial is testingSafety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal CancerWho this might be right forOvarian CarcinomaPeritoneal Carcinoma InterMune 847
Early research (Phase 1)Study completedNCT02668393What this trial is testingNintedanib and Weekly Docetaxel in Lung AdenocarcinomaWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Study completedNCT01161316What this trial is testingSafety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS TumoursWho this might be right forMetastatic Colorectal Cancer Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 194
Post-approval studies (Phase 4)Study completedNCT00706706What this trial is testingSafety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Pfizer 105
Post-approval studies (Phase 4)Study completedNCT01498887What this trial is testingEfficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying TherapyWho this might be right forRelapsing Remitting Multiple Sclerosis Novartis Pharmaceuticals 347